Dose Monitoring Device Market by Type, Application

List of Tables

The Dose Monitoring Device Market was valued at USD 3.32 billion in 2023, expected to reach USD 3.60 billion in 2024, and is projected to grow at a CAGR of 8.62%, to USD 5.92 billion by 2030.

Dose monitoring devices are critical tools in healthcare that regulate and track the administered dosage of medications, particularly in settings requiring precise dosing such as oncology, pain management, and chronic disease treatment. These devices play a crucial role in improving patient outcomes by minimizing medication errors and optimizing therapeutic protocols. The necessity for accurate dose monitoring is driven by the increasing incidence of chronic diseases, a growing elderly population, and the heightened focus on personalized medicine. Applications span across hospitals, clinics, and home healthcare environments, offering varied use cases from intravenous drug delivery systems to inhalers and implantable devices.

KEY MARKET STATISTICS
Base Year [2023]	USD 3.32 billion
Estimated Year [2024]	USD 3.60 billion
Forecast Year [2030]	USD 5.92 billion
CAGR (%)	8.62%

Key growth factors in this market include technological advancements, such as the integration of IoT and AI for real-time monitoring and data analytics. This integration enhances medication safety and fosters remote patient monitoring. The ongoing digital transformation in healthcare also presents potential opportunities, with increasing investments in smart health solutions providing a fertile ground for innovation. Companies focusing on developing interoperable systems that can seamlessly integrate with electronic health records (EHRs) stand to gain a competitive edge. However, the market faces limitations like stringent regulatory frameworks and high costs associated with advanced devices, which can pose barriers to access and widespread adoption.

Moreover, there is a challenge in achieving data standardization and ensuring cybersecurity, given the sensitive nature of health information. To counter these challenges and maximize growth potential, ongoing research and development should be directed towards enhancing device accuracy, miniaturization, and user-friendliness. Exploring partnerships with healthcare providers for real-world system testing and validation can also accelerate innovation. As precision medicine continues to evolve, areas such as predictive dosing models and personalized medication management systems offer promising avenues for research and development. Overall, the dose monitoring device market is poised for growth, but success hinges on balancing innovation with regulatory compliance and cost-efficiency.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dose Monitoring Device Market

The Dose Monitoring Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing aging population and rising incidence of chronic diseases globally
- Growing investments by healthcare systems and individuals in imaging technologies
- Rising use of diagnostic imaging modalities and the increasing awareness regarding radiation safety
Market Restraints
- High cost associated with the advanced dose monitoring technologies
Market Opportunities
- Ongoing advancements in dose monitoring technologies
- Enhancing interoperability of dose monitoring technologies with advanced imaging technologies
Market Challenges
- Data privacy and security concerns associated with the use of digital and connected dose monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Dose Monitoring Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dose Monitoring Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dose Monitoring Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dose Monitoring Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dose Monitoring Device Market

A detailed market share analysis in the Dose Monitoring Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dose Monitoring Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dose Monitoring Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dose Monitoring Device Market

A strategic analysis of the Dose Monitoring Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dose Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bracco S.p.A., Canon Inc., Dozee, Fuji Electric Co., Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Infab Corporation, INFINITT Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Inc. by Fortive Corporation, Medic Vision, Medsquare, Mirion Technologies, Inc., Novarad Corporation, PACSHealth, LLC, QAELUM NV, RaySafe by Fluke Corporation, Sectra AB, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and Volpara Health Limited.

Market Segmentation & Coverage

This research report categorizes the Dose Monitoring Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Active and Passive. The Active is further studied across Active Area Dosimeters and Electronic Personal Dosimeters (EPDs). The Passive is further studied across Film Badges, Optically Stimulated Luminescence Dosimeters (OLDs), Pocket lonization Chambers, and Thermoluminescent Dosimeters (TLDs).
Based on Application, market is studied across Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography, and Radiography.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-A413C23B631F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing aging population and rising incidence of chronic diseases globally
  - 5.1.1.2. Growing investments by healthcare systems and individuals in imaging technologies
  - 5.1.1.3. Rising use of diagnostic imaging modalities and the increasing awareness regarding radiation safety
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with the advanced dose monitoring technologies
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in dose monitoring technologies
  - 5.1.3.2. Enhancing interoperability of dose monitoring technologies with advanced imaging technologies
- 5.1.4. Challenges
  - 5.1.4.1. Data privacy and security concerns associated with the use of digital and connected dose monitoring devices
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing use of passive dose monitoring devices owing to their accuracy, reusability, and long-term exposure tracking capability
- 5.2.2. Application: Extensive use of dose monitoring devices in computed radiography (CR) to manage and optimize radiation doses
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Dose Monitoring Device Market, by Type

6.1. Introduction
6.2. Active
- 6.2.1. Active Area Dosimeters
- 6.2.2. Electronic Personal Dosimeters (EPDs)
6.3. Passive
- 6.3.1. Film Badges
- 6.3.2. Optically Stimulated Luminescence Dosimeters (OLDs)
- 6.3.3. Pocket lonization Chambers
- 6.3.4. Thermoluminescent Dosimeters (TLDs)

7. Dose Monitoring Device Market, by Application

7.1. Introduction
7.2. Computed Radiography
7.3. Fluoroscopy & Interventional Imaging
7.4. Mammography
7.5. Radiography

8. Americas Dose Monitoring Device Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Dose Monitoring Device Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Dose Monitoring Device Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. Dozee introduces ambulatory connected patient monitoring system Dozee Pro Ex'
- 11.3.2. FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
- 11.3.3. Tracerco announces launch of next generation personal electronic dosimeter range - Tracerco PED2
11.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Bayer AG
2. Bracco S.p.A.
3. Canon Inc.
4. Dozee
5. Fuji Electric Co., Ltd.
6. Fujifilm Holdings Corporation
7. GE HealthCare Technologies, Inc.
8. Guerbet
9. IBA Dosimetry GmbH
10. Infab Corporation
11. INFINITT Healthcare Co., Ltd.
12. Koninklijke Philips N.V.
13. LANDAUER, Inc. by Fortive Corporation
14. Medic Vision
15. Medsquare
16. Mirion Technologies, Inc.
17. Novarad Corporation
18. PACSHealth, LLC
19. QAELUM NV
20. RaySafe by Fluke Corporation
21. Sectra AB
22. Siemens Healthineers AG
23. Thermo Fisher Scientific, Inc.
24. Volpara Health Limited